Association of single nucleotide polymorphisms in the diamine oxidase gene with diamine oxidase serum activities

  title={Association of single nucleotide polymorphisms in the diamine oxidase gene with diamine oxidase serum activities},
  author={Laura Maintz and C.-F. Yu and Elke Rodriguez and Hansj{\"o}rg Baurecht and Thomas Bieber and Thomas Illig and Stephan Weidinger and Natalija Novak},
To cite this article: Maintz L, Yu C‐F, Rodríguez E, Baurecht H, Bieber T, Illig T, Weidinger S, Novak N. Association of single nucleotide polymorphisms in the diamine oxidase gene with diamine oxidase serum activities. Allergy 2011; 66: 893–902. 

Diamine Oxidase rs10156191 and rs2052129 Variants Are Associated With the Risk for Migraine

This work investigated the possible association between functional single nucleotide polymorphisms in the diamine oxidase gene (DAO; chromosome 7q36.1, involved in histamine metabolism) and the risk for migraine.

Increased serum diamine oxidase activity in nonallergic patients with migraine

This work investigated the possible relationship of serum DAO activity and histamine levels and 3 polymorphisms in the DAO gene with the risk for migraine.

Association of diamine oxidase and histamine N-methyltransferase polymorphisms with presence of migraine in a group of Mexican mothers of children with allergies

Facultad de Medicina, Departamento de Investigación, Universidad Juárez del Estado de Durango, Campus Gómez Palacio, urango, Mexico Facultad de Medicina, Centro de Investigación Biomédica,

Diamine oxidase levels in different chronic urticaria phenotypes.

Serum diamine oxidase activity in patients with histamine intolerance

In patients with symptoms triggered by histamine-rich food, measuring the serum diamine oxidation activity can help identify subjects who can benefit from a histamine limitation diet and/or diamine oxidase supplementation.

Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study

HIT is characterized by typical symptoms and low levels of DAO activity, and patients with DAO values between 3 and 10 U/mL show the best response to treatment (low-histamine diet and/or DAO supplementation).

Circadian profiling reveals higher histamine plasma levels and lower diamine oxidase serum activities in 24% of patients with suspected histamine intolerance compared to food allergy and controls

The aim of the study was to establish day profiles of histamine levels and DAO activities, and to compare the results between patients with suspected histamine intolerance, food allergy and healthy controls.



Analysis of diamine oxidase gene polymorphisms in patients with inflammatory bowel disease

A simple genetic test is proposed using blood samples that would allow identification of DAO alleles associated with altered DAO activity and predisposition to inflammatory bowel disease.

Genetic variability of human diamine oxidase: occurrence of three nonsynonymous polymorphisms and study of their effect on serum enzyme activity

Nonsynonymous ABP1 gene polymorphisms are common in humans; they cause relevant functional effects and can be considered as major determinants of variability for human diamine oxidase activity.

Genetic polymorphisms of histamine degrading enzymes: From small-scale screening to high-throughput routine testing

Single nucleotide polymorphisms of genes encoding the histamine degrading enzymes diamine oxidase and histamine N-methyltransferase are analyzed to find possible associations of certain polymorphic markers with the development of diseases where alterations in histamine metabolism have been described.

Determination of diamine oxidase activity in normal human blood serum.

The method with 14C-putrescine as the substrate for routine measurement of serum (plasma) diamine oxidase (histaminase) during pregnancy, and mola hydatidosa (chorionepitelioma) has been modified.

Histamine N-methyltransferase and diamine oxidase gene polymorphisms in patients with inflammatory and neoplastic intestinal diseases

Since histamine has been implicated as a mediator of inflammatory and neoplastic processes, it was asked whether any of the known polymorphisms of genes encoding HNMT and DAO might be associated with an increased risk of developing inflammatory or neoplastics intestinal diseases.

Histamine‐N‐Methyl Transferase Polymorphism and Risk for Migraine

Investigation of the possible association between HNMT polymorphism and the risk for migraine found one of these single nucleotide polymorphisms causes the amino acid substitution Thr105Ile, related to decreased enzyme activity.

The human gene for diamine oxidase, an amiloride binding protein. Molecular cloning, sequencing, and characterization of the promoter.

The analysis of the organization of the sequence of the human ABP/DAO gene reveals that the 2.4-kilobase messenger RNA is transcribed from two close origins identifying the proximal promoter.

Histamine pharmacogenomics.

This review summarizes relevant polymorphisms, discusses controversial findings on association of histamine-related polymorphisms and allergies and other diseases, and identifies topics requiring further investigation.

Intestinal diamine oxidases and enteral-induced histaminosis: studies on three prognostic variables in an epidemiological model.

Elevated plasma histamine in pigs acts as a pathogenetic factor for the disease manifestation, and the trias of variables shown in this study should be consequently investigated in man.

Food-induced histaminosis as an epidemiological problem: Plasma histamine elevation and haemodynamic alterations after oral histamine administration and blockade of diamine oxidase (DAO)

The results contradict the current opinion that oral histamine intake in food is not clinically relevant, especially since many commonly used drugs are DAO-inhibitors and approximately 20% of the authors' population take these drugs.